Hopefully they can fill within the month since Dr. Lalezari has been working with and treating HIV patients, and can more easily and quickly get the amount of trial candidates needed.

It would be great if some of the folks here who've had such good questions have submitted them to CytoDyn. I sent in a couple last night, primarily about the competition out there regarding Glioblastoma, and where Leronlimab might stand as well as what chance it has to have an impact. I suppose same can be asked about inflammation/HIV.

They stated in their release that while they're not taking any questions today, that concerns can be emailed to them.